Elevate your local knowledge
Sign up for the iNFOnews newsletter today!

NEW YORK, N.Y. – Drugstore chain CVS Caremark Corp. says it has agreed to buy the drug infusion business Coram LLC, a unit of Apria Healthcare Group Inc., for $2.1 billion.
Coram, which is based in Denver, provides customers with medication and nutrition that is administered through a vein. The medication can be delivered to a customer’s home, clinic or doctor’s office.
CVS expects the deal to close by the end of the first quarter of 2014.
CVS expects Coram to generate revenue of about $1.4 billion in the first year after the deal closes and add earnings of between 3 cents per share and 5 cents per share in 2015.
Apria Healthcare Group Inc., Coram’s parent company, is owned by investment firm The Blackstone Group LP.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Want to share your thoughts, add context, or connect with others in your community?
You must be logged in to post a comment.